Theranostics combine PSMA imaging with targeted radiation therapy to help locate and treat advanced prostate cancer using the ...

For the hundreds of thousands of men who undergo radical prostatectomy each year, one question looms over every postoperative ...

For decades, the diagnosis of clinically significant prostate cancer has rested on an uncomfortable compromise.

Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians ...

BiPASS for Pre-Biopsy PSMA-PET Imaging in Prostate Cancer / BiPASS, cancer, cancer care, Cancer research, cancer treatment, ...

Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agentBEDFORD, Mass., Sept. 30, ...

India has 0.3 PET-CT scanners per million population, way below the World Health Organization standard of 2 and the American ...

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

Case report highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that ...

There is a moment in a prostate cancer consultation when I sometimes wish I could slow time down. The patient has already been through the blood test, the scan and ...

Get latest articles and stories on Business at LatestLY. Ahmedabad (Gujarat) [India], September 29: Cancer treatment is ...

Genomic testing in high-risk prostate cancer remains underutilized nationally, driven by fragmented ordering and interpretive ...